We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9,
Telephone: +353 1 295 9620
Fax: : +353 1 816 3642
Medical Information e-mail: Medinfo@dbl.boehringer-ingelheim.com
Patient Information Leaflet last updated on medicines.ie: 17/08/2017
PIL Synjardy film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/08/2017 and displayed until Current
Reasons for adding or updating:
  • Improved presentation of PIL
Updated on 09/08/2017 and displayed until 17/08/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 05/07/2017 and displayed until 09/08/2017
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Updated on 07/06/2017 and displayed until 05/07/2017
Reasons for adding or updating:
  • Change to other sources of information section
  • Improved presentation of PIL
Updated on 11/05/2017 and displayed until 07/06/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision
Updated on 16/03/2017 and displayed until 11/05/2017
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 13/01/2017 and displayed until 16/03/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - dose and frequency
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - manufacturer
Updated on 08/08/2016 and displayed until 13/01/2017
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 20/05/2016 and displayed until 08/08/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 19/11/2015 and displayed until 20/05/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about overdose
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 01/09/2015 and displayed until 19/11/2015
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Metformin Hydrochloride
   Empagliflozin